Skip to content

Study comparing two techniques for pain control after laparoscopic cholecystectomy

Comparison between TAP block and intravenous multimodal analgesia for pain control after Laparoscopic Cholecystectomy: a randomized double-blind clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-25kdrrz
Enrollment
80
Registered
2026-07-16
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Nausea and Vomiting Postoperative Pain

Interventions

Thirty participants will be randomly allocated into two groups in a randomized, double-blind clinical trial. Group 1 (n=15), Transversus Abdominis Plane Block group: participants will receive a bilate

Sponsors

Hospital Naval Marcílio Dias
Lead Sponsor
Instituto de Pesquisas Biomédicas do Hospital Naval Marcílio Dias
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Users of the Brazilian Navy Health System; both sexes; age between 18 and 70 years; American Society of Anesthesiologists physical status I or II; indication for elective Laparoscopic Cholecystectomy; provision of voluntary informed consent

Exclusion criteria

Exclusion criteria: Refusal to participate; age lower than 18 years or greater than 70 years; American Society of Anesthesiologists physical status greater than II; allergy to any study medication; Emergency Surgery; Chronic Pain; Acalculous Biliary Disease; pregnancy; class III obesity with body mass index greater than 35 kilograms per square meter

Design outcomes

Primary

MeasureTime frame
Evaluate postoperative opioid consumption within the first 24 hours after surgery; verified by measuring the cumulative dose of rescue opioids administered during the postoperative period, expressed as morphine milligram equivalents; lower opioid consumption is expected in the transversus abdominis plane block group compared with the intravenous multimodal analgesia group

Secondary

MeasureTime frame
Evaluate postoperative pain intensity 15 minutes after admission to the post-anesthesia care unit; verified using the Visual Analog Scale for pain assessment; lower pain scores are expected in the transversus abdominis plane block group compared with the intravenous multimodal analgesia group;Evaluate postoperative pain intensity 60 minutes after admission to the post-anesthesia care unit; verified using the Visual Analog Scale for pain assessment; lower pain scores are expected in the transversus abdominis plane block group compared with the intravenous multimodal analgesia group;Evaluate postoperative pain intensity within the first 24 hours after surgery; verified using the Visual Analog Scale for pain assessment; lower pain scores are expected in the transversus abdominis plane block group compared with the intravenous multimodal analgesia group;Evaluate the incidence of Postoperative Nausea and Vomiting within the first 24 hours after surgery; verified through standardized clinical assessment and the need for rescue antiemetic medication; lower incidence of Postoperative Nausea and Vomiting is expected in the transversus abdominis plane block group compared with the intravenous multimodal analgesia group;Evaluate hospital length of stay after surgery; verified by measuring the time interval in hours between the end of surgery and hospital discharge; shorter hospital stay is expected in the transversus abdominis plane block group compared with the intravenous multimodal analgesia group;Evaluate patient satisfaction with postoperative analgesia within the first 24 hours after surgery; verified using a standardized satisfaction scale; higher satisfaction scores are expected in the transversus abdominis plane block group compared with the intravenous multimodal analgesia group

Countries

BR

Contacts

Public ContactBruno Santiago

Hospital Naval Marcílio Dias

bruno.santiago@hupe.uerj.br+55(21)998124-018

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Aug 10, 2026